Together, well review your medical history and goals to create a program tailored to your needs
Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist with a slightly different mechanism
Lets look at the actual data, not the marketing spin
Ozempic also contains semaglutide, but it is more closely associated with type 2 diabetes management, even though many people discuss it for weight loss
This is the only study dissecting the association of MEIS1 with insomnia symptoms and RLS using a sample of patients with chronic insomnia disorder, which had been phenotyped for both diseases by clinicians
Companies that cut corners, skip clinical standards, or mislead patients damage trust in the entire industry